Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer
Journal
The oncologist
Journal Volume
26
Journal Issue
9
Pages
e1548
Date Issued
2021-09
Author(s)
Sanduleanu, Silvia
Abstract
With the implementation of screening programs worldwide, diagnosis of early-stage colorectal cancer steadily increased, including T1 cancer. Current T1 cancer treatment does not differ according to anatomic location. We therefore compared the disease-free survival of T1 cancer arising from the rectum versus the colon.
Subjects
Anatomic location; Colorectal cancer; Disease-free survival; T1 cancer
SDGs
Other Subjects
carcinoembryonic antigen; adjuvant chemotherapy; adjuvant radiotherapy; advanced cancer; Article; cancer adjuvant therapy; cancer recurrence; cancer risk; cancer size; cancer staging; cancer surgery; cancer survival; cancer therapy; chromoendoscopy; cohort analysis; colon cancer; colonoscopy; colorectal cancer; disease free survival; endoscopic mucosal resection; endoscopic submucosal dissection; endoscopic surgery; endoscopy; esophagogastroduodenoscopy; female; follow up; histology; histopathology; human; human tissue; intestine preparation; length of stay; lymph node dissection; major clinical study; male; metastasis; narrow band imaging; neck dissection; neutrophil lymphocyte ratio; outcome assessment; overall survival; polypectomy; prevalence; rectum cancer; recurrence risk; retrospective study; risk assessment; risk factor; smoking; tonsillectomy; tumor invasion; tumor recurrence; aged; colon tumor; lymph node metastasis; middle aged; pathology; rectum; rectum tumor; Aged; Colonic Neoplasms; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Rectum; Retrospective Studies
Publisher
WILEY
Type
journal article